Shimeng Li
Impact in
-
- Lipid metabolism and biosynthesis
-
- Nitrogen and Sulfur Effects on Brassica
- Protein Degradation and Inhibitors
- Genomics, phytochemicals, and oxidative stress
- Ubiquitin and proteasome pathways
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 2
- Photosynthetic Processes and Mechanisms 2
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Jiana Li (3 shared papers)Ledong Jia (2 shared papers)Kun Lu (2 shared papers)Xinfu Xu (2 shared papers)Huiyan Zhao (2 shared papers)Cunmin Qu (2 shared papers)Rui Wang (1 shared paper)Ying Liang (1 shared paper)
- Journals
- International Immunopharmacology (2 papers)Frontiers in Pharmacology (2 papers)Urban Rail Transit (1 paper)Annals of Palliative Medicine (1 paper)Medicine (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Shimeng Li
23 papers receiving 284 citations
Shimeng Li's Hit Papers
Peers
Comparison fields: 5 of 67
- Biochemistry 41
- Molecular Biology 161
- Plant Science 75
- Oncology 35
- Health, Toxicology and Mutagenesis 17
Countries citing papers authored by Shimeng Li
This map shows the geographic impact of Shimeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shimeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shimeng Li more than expected).
Fields of papers citing papers by Shimeng Li
This network shows the impact of papers produced by Shimeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shimeng Li. The network helps show where Shimeng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Shimeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 63 | |
| 2 | PROTAC-DB 3.0: an updated database of PROTACs with extended pharmacokinetic parameters Hit paper breakdown → | 2024 | 44 |
| 3 | 2015 | 39 | |
| 4 | 2023 | 22 | |
| 5 | 2022 | 21 | |
| 6 | 2021 | 13 | |
| 7 | 2022 | 10 | |
| 8 | 2020 | 9 | |
| 9 | 2018 | 9 | |
| 10 | 2022 | 8 | |
| 11 | 2023 | 7 | |
| 12 | 2021 | 7 | |
| 13 | 2020 | 7 | |
| 14 | 2019 | 6 | |
| 15 | 2023 | 4 | |
| 16 | 2025 | 3 | |
| 17 | 2019 | 3 | |
| 18 | 2024 | 2 | |
| 19 | 2025 | 2 | |
| 20 | 2019 | 2 |
About Shimeng Li
Shimeng Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Biochemistry and Physiology, having authored 27 papers that have together received 284 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Lipid metabolism and biosynthesis (4 papers), Lung Cancer Treatments and Mutations (4 papers), Plant Stress Responses and Tolerance (2 papers), Sarcoidosis and Beryllium Toxicity Research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Peptidase Inhibition and Analysis (2 papers) and Photosynthetic Processes and Mechanisms (2 papers). The work is most often cited by research in Biochemistry (41 citations), Molecular Biology (161 citations), Plant Science (75 citations), Oncology (35 citations) and Health, Toxicology and Mutagenesis (17 citations). Shimeng Li has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Jiana Li, Ledong Jia, Kun Lu, Xinfu Xu, Huiyan Zhao, Cunmin Qu, Rui Wang, Ying Liang, Lijuan Wei and Fuyou Fu. Their work appears in journals such as International Immunopharmacology, Frontiers in Pharmacology, Urban Rail Transit, Annals of Palliative Medicine and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.